BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 32087016)

  • 1. Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution.
    Vasin S; Philipp A; Floerchinger B; Rastogi P; Lunz D; Mueller T; Schmid C; Camboni D
    Interact Cardiovasc Thorac Surg; 2020 May; 30(5):711-714. PubMed ID: 32087016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics with mechanical circulatory support devices using a cardiogenic shock model.
    Yahagi K; Nishimura G; Kuramoto K; Tsuboko Y; Iwasaki K
    Sci Rep; 2024 Jun; 14(1):14125. PubMed ID: 38898087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant implantation of Impella
    Pappalardo F; Schulte C; Pieri M; Schrage B; Contri R; Soeffker G; Greco T; Lembo R; Müllerleile K; Colombo A; Sydow K; De Bonis M; Wagner F; Reichenspurner H; Blankenberg S; Zangrillo A; Westermann D
    Eur J Heart Fail; 2017 Mar; 19(3):404-412. PubMed ID: 27709750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impella to unload the left ventricle in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock: A systematic review and meta-analysis.
    Grajeda Silvestri ER; Pino JE; Donath E; Torres P; Chait R; Ghumman W
    J Card Surg; 2020 Jun; 35(6):1237-1242. PubMed ID: 32531130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impella Versus Intra-Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study.
    Yeo I; Axman R; Lu DY; Feldman DN; Cheung JW; Minutello RM; Karas MG; Iannacone EM; Srivastava A; Girardi NI; Naka Y; Wong SC; Kim LK
    J Am Heart Assoc; 2024 Feb; 13(3):e032607. PubMed ID: 38240236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECMO and Impella Support Strategies as a Bridge to Surgical Repair of Post-Infarction Ventricular Septal Rupture.
    Coyan G; Anand N; Imran M; Gomez H; Ramanan R; Murray H; Sanon S; Yoon P; Kaczorowski D; Bonatti J
    Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35630028
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of Impella and mechanical devices in cardiogenic shock.
    Chera HH; Nagar M; Chang NL; Morales-Mangual C; Dous G; Marmur JD; Ihsan M; Madaj P; Rosen Y
    Expert Rev Med Devices; 2018 Apr; 15(4):293-299. PubMed ID: 29600725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model.
    Møller-Helgestad OK; Hyldebrandt JA; Banke A; Rud CS; Udesen NLJ; Linde L; Okkels-Jensen L; Schmidt H; Ravn HB; Møller JE
    EuroIntervention; 2019 Feb; 14(15):e1585-e1592. PubMed ID: 30418160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after refractory cardiogenic shock is comparable in patients with Impella and veno-arterial extracorporeal membrane oxygenation when adjusted for SAVE score.
    Schiller P; Hellgren L; Vikholm P
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):329-337. PubMed ID: 30406678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical circulatory support in cardiogenic shock from acute myocardial infarction: Impella CP/5.0 versus ECMO.
    Karami M; den Uil CA; Ouweneel DM; Scholte NT; Engström AE; Akin S; Lagrand WK; Vlaar AP; Jewbali LS; Henriques JP
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):164-172. PubMed ID: 31353918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock.
    Tongers J; Sieweke JT; Kühn C; Napp LC; Flierl U; Röntgen P; Schmitto JD; Sedding DG; Haverich A; Bauersachs J; Schäfer A
    Circ Heart Fail; 2020 Mar; 13(3):e005853. PubMed ID: 32164431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate.
    Bertoldi LF; Pappalardo F; Lubos E; Grahn H; Rybczinski M; Barten MJ; Legros T; Bertoglio L; Schrage B; Westermann D; Lapenna E; Reichenspurner H; Bernhardt AM
    J Crit Care; 2020 Jun; 57():259-263. PubMed ID: 32061461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock.
    Patel SM; Lipinski J; Al-Kindi SG; Patel T; Saric P; Li J; Nadeem F; Ladas T; Alaiti A; Phillips A; Medalion B; Deo S; Elgudin Y; Costa MA; Osman MN; Attizzani GF; Oliveira GH; Sareyyupoglu B; Bezerra HG
    ASAIO J; 2019 Jan; 65(1):21-28. PubMed ID: 29489461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Lüsebrink E; Kellnar A; Krieg K; Binzenhöfer L; Scherer C; Zimmer S; Schrage B; Fichtner S; Petzold T; Braun D; Peterss S; Brunner S; Hagl C; Westermann D; Hausleiter J; Massberg S; Thiele H; Schäfer A; Orban M
    Circulation; 2022 Apr; 145(16):1254-1284. PubMed ID: 35436135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial Infarction.
    Mourad M; Gaudard P; De La Arena P; Eliet J; Zeroual N; Rouvière P; Roubille F; Albat B; Colson PH
    ASAIO J; 2018; 64(6):708-714. PubMed ID: 29240628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report.
    Ebert D; Mungard N; Mensch A; Homeister L; Willsch J; Ibe R; Baust H; Stiller M; Rebelo A; Ukkat J; Rigopoulos AG; Weber E; Bucher M; Noutsias M
    BMC Cardiovasc Disord; 2021 Nov; 21(1):528. PubMed ID: 34743690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis Comparing Venoarterial Extracorporeal Membrane Oxygenation With or Without Impella in Patients With Cardiogenic Shock.
    Bhatia K; Jain V; Hendrickson MJ; Aggarwal D; Aguilar-Gallardo JS; Lopez PD; Narasimhan B; Wu L; Arora S; Joshi A; Tomey MI; Mahmood K; Qamar A; Birati EY; Fox A
    Am J Cardiol; 2022 Oct; 181():94-101. PubMed ID: 35999070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of pulmonary congestion in patients undergoing venoarterial extracorporeal membrane oxygenation for cardiogenic shock.
    Lüsebrink E; Orban M; Kupka D; Scherer C; Hagl C; Zimmer S; Luedike P; Thiele H; Westermann D; Massberg S; Schäfer A; Orban M
    Eur Heart J; 2020 Oct; 41(38):3753-3761. PubMed ID: 33099278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 20. Veno-arterial extracorporeal membrane oxygenation with concomitant Impella versus concomitant intra-aortic-balloon-pump for cardiogenic shock.
    Au SY; Fong KM; Tsang CS; Chan KA; Wong CY; Ng WG; Lee KYM
    Perfusion; 2023 Jan; 38(1):51-57. PubMed ID: 34318736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.